RU2019128331A - Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина - Google Patents

Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина Download PDF

Info

Publication number
RU2019128331A
RU2019128331A RU2019128331A RU2019128331A RU2019128331A RU 2019128331 A RU2019128331 A RU 2019128331A RU 2019128331 A RU2019128331 A RU 2019128331A RU 2019128331 A RU2019128331 A RU 2019128331A RU 2019128331 A RU2019128331 A RU 2019128331A
Authority
RU
Russia
Prior art keywords
insulin
pharmaceutical composition
derivative
kit
analogue
Prior art date
Application number
RU2019128331A
Other languages
English (en)
Russian (ru)
Inventor
Оливер БЛЕЙ
Петра ЛООС
Бернд БИДЛИНГМАЙЕР
Вальтер Камм
Харальд БЕРХТОЛЬД
Original Assignee
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи filed Critical Санофи
Publication of RU2019128331A publication Critical patent/RU2019128331A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
RU2019128331A 2013-02-04 2014-02-03 Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина RU2019128331A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP13305126.8 2013-02-04
EP13305126 2013-02-04
US201361761434P 2013-02-06 2013-02-06
US61/761,434 2013-02-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2015137674A Division RU2702345C2 (ru) 2013-02-04 2014-02-03 Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина

Publications (1)

Publication Number Publication Date
RU2019128331A true RU2019128331A (ru) 2019-12-16

Family

ID=66013563

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019128331A RU2019128331A (ru) 2013-02-04 2014-02-03 Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина

Country Status (5)

Country Link
JP (2) JP6698797B2 (es)
ES (1) ES2804719T3 (es)
PT (1) PT2950780T (es)
RU (1) RU2019128331A (es)
SG (1) SG10201913433SA (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201913433SA (en) * 2013-02-04 2020-03-30 Sanofi Sa Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
CN110721154A (zh) * 2019-10-28 2020-01-24 南京圣鼎医药科技有限公司 一种恩格列净口服溶液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107941A (ja) * 1985-11-28 1988-05-12 Wakunaga Pharmaceut Co Ltd 制ガン剤
US8710000B2 (en) * 2007-11-08 2014-04-29 Novo Nordisk A/S Insulin derivative
KR101766927B1 (ko) * 2009-04-01 2017-08-09 제넨테크, 인크. 인슐린 저항성 장애의 치료
CA2764423A1 (en) * 2009-06-26 2010-12-29 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
US20130331320A1 (en) * 2010-12-14 2013-12-12 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
EP2720712B1 (en) * 2011-06-17 2016-03-02 Halozyme, Inc. Stable formulations of a hyaluronan-degrading enzyme
SG10201913433SA (en) * 2013-02-04 2020-03-30 Sanofi Sa Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives

Also Published As

Publication number Publication date
JP6698797B2 (ja) 2020-05-27
JP2020128395A (ja) 2020-08-27
SG10201913433SA (en) 2020-03-30
ES2804719T3 (es) 2021-02-09
PT2950780T (pt) 2020-07-07
JP2019052162A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
RU2015137674A (ru) Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина
RU2016132386A (ru) Стабилизированные фармацевтические составы без глицерина на основе инсулиновых аналогов и/или инсулиновых производных
RU2016132342A (ru) Стабилизированные фармацевтические составы на основе инсулиновых аналогов и/или инсулиновых производных
RU2016132340A (ru) Стабилизированные фармацевтические составы на основе инсулина аспарта
HRP20181028T1 (hr) Dugodjelujuće formulacije inzulina
ES2360505T3 (es) Preparados de insulina libre de zinc o con bajo contenido en cinc con estabilidad mejorada.
ES2365410T3 (es) Formulaciones farmacéuticas que comprenden péptido de incretina y un disolvente polar aprótico.
RU2313362C2 (ru) Кислые инсулиновые препараты с повышенной стабильностью
JP6249773B2 (ja) インスリン−亜鉛錯体の調製方法
KR101978527B1 (ko) 펩티드 약물의 비경구 주입을 위한 안정한 제형
US9993555B2 (en) Rapid-acting insulin compositions
RU2012123739A (ru) Фармацевтическая композиция, содержащая агонист гпп-1 и метионин
JP2011241213A5 (es)
WO2010014946A3 (en) Halogen-stabilized insulin
JP2016539921A5 (es)
AR077455A1 (es) Preparaciones insulinicas de accion lenta
US20150119323A1 (en) Stable Formulation of Insulin Glulisine
MY181626A (en) Treatment of diabetes mellitus by long-acting formulations of insulins
RU2016107610A (ru) Фармацевтическая композиция
RU2019128331A (ru) Стабилизированные фармацевтические составы аналогов инсулина и/или производные инсулина
RU2020140694A (ru) Способ лечения гипергликемии
EP2906234A1 (de) Kompositionen auf basis von hormonen der hypophyse, zur zugabe in infusionsflüssigkeiten
RU2022119802A (ru) Композиции инсулинов длительного действия
WO2017163159A1 (en) Biphasic pharmaceutical composition of insulin human
RU2625737C2 (ru) Шипучий фитоминеральный комплекс с антидиабетическим действием